Biology · Oct / Nov 2024 · Paper 11 · Question 5
YBI11
As printed in the paper
The question as text
5 Warfarin is used as an anticoagulant to treat some patients. Patients respond differently to this drug. This makes it difficult for doctors to select a safe but effective dose of warfarin to give to each patient. Factors that affect the response of a patient to warfarin include age, body mass, liver function and genetic makeup.
Read automatically from the paper; the printed page above is exact.
Show the answer and mark scheme
5(a)[2]
A description that includes the following points:
to carry a copy of the gene {out of the nucleus / into the
ACCEPT {(genetic) code / DNA base
cytoplasm / to the ribosomes} (1)
sequence / DNA} if reference to the
enzyme has been made
NB copy is the noun not the verb
(used for) {(correct) ordering of the amino acids / producing
amino acid sequence / formation of (poly)peptide chain} (1)
Advantages of pharmacogenomics:
genotype {affects / determines} the dose of warfarin neededso one dose will not be appropriate for all patientsas the two genes that have several alleles(one / two) gene M allele that slows down breakdown means less warfarin accept converse for other allelesone gene V allele results in less enzyme V / mRNA so less warfarin should be prescribed – accept converse for other allelesother genetic predispositions maybe identified e.g. high cholesterol, high blood pressureEffect of other factors:
factors other than genotype affects blood clotting so these would need to be taken into account as welle.g. people with high cholesterol more likely to be prescribed warfarinmass of warfarin would need to be adjusted according to body size / given at a particular dose in mgs per kgliver function may affect the half life of the drugIssues surrounding genetic screening:
there are religious / moral / social / ethical issues relating to genetic screening
people / family may not want to find out if there are any other underlying genetic issues
possibility of false negative / positive results
Blood clotting:
thromboplastin converts prothrombin into thrombin which converts fibrinogen into fibrin to trap platelets
Level 0
0
No awardable content
Level 1
12
Demonstrates isolated elements of biological knowledge and
Simple points made
understanding to the given context with generalised comments made.
Vague statements related to consequences are made with limited linkage
1 mark = 1 point made
to a range of scientific ideas, processes, techniques and procedures. The
2 marks = some attempt to comment on pharmacogenetics
discussion will contain basic information with some attempt made to link
or factors that affect it
knowledge and understanding to the given context.
OR
description of blood clotting process
Level 2
34
Demonstrates adequate knowledge and understanding by selecting and
Simple discussion of pharmacogenetics
applying some relevant biological facts / concepts. Consequences are
discussed which are occasionally supported through linkage to a range of
3 marks = implications of genotype for either gene M or
scientific ideas, processes, techniques and procedures. The discussion
gene V on warfarin dose
shows some linkages and lines of scientific reasoning with some
4 marks = implications of genotype for both gene M and
structure.
gene V on warfarin dose
Level 3
56
Demonstrates comprehensive knowledge and understanding by selecting
Understanding of other issues involved
and applying relevant biological facts / concepts. Consequences are
discussed which supported throughout by sustained linkage to a range of
5 marks = criteria for 4 marks plus links made with either
scientific ideas, processes, techniques and procedures. The discussion
blood clotting process or other factors or issues of
shows a welldeveloped and sustained line of scientific reasoning which is
screening
clear and logically structured.
6 marks = criteria for 4 marks plus links made with two
from blood clotting process / other factors / issues
surrounding screening
5(b)(i)[8]
A description that includes the following points:
to carry a copy of the gene {out of the nucleus / into the
ACCEPT {(genetic) code / DNA base
cytoplasm / to the ribosomes} (1)
sequence / DNA} if reference to the
enzyme has been made
NB copy is the noun not the verb
(used for) {(correct) ordering of the amino acids / producing
amino acid sequence / formation of (poly)peptide chain} (1)
Advantages of pharmacogenomics:
genotype {affects / determines} the dose of warfarin neededso one dose will not be appropriate for all patientsas the two genes that have several alleles(one / two) gene M allele that slows down breakdown means less warfarin accept converse for other allelesone gene V allele results in less enzyme V / mRNA so less warfarin should be prescribed – accept converse for other allelesother genetic predispositions maybe identified e.g. high cholesterol, high blood pressureEffect of other factors:
factors other than genotype affects blood clotting so these would need to be taken into account as welle.g. people with high cholesterol more likely to be prescribed warfarinmass of warfarin would need to be adjusted according to body size / given at a particular dose in mgs per kgliver function may affect the half life of the drugIssues surrounding genetic screening:
there are religious / moral / social / ethical issues relating to genetic screening
people / family may not want to find out if there are any other underlying genetic issues
possibility of false negative / positive results
Blood clotting:
thromboplastin converts prothrombin into thrombin which converts fibrinogen into fibrin to trap platelets
Level 0
0
No awardable content
Level 1
12
Demonstrates isolated elements of biological knowledge and
Simple points made
understanding to the given context with generalised comments made.
Vague statements related to consequences are made with limited linkage
1 mark = 1 point made
to a range of scientific ideas, processes, techniques and procedures. The
2 marks = some attempt to comment on pharmacogenetics
discussion will contain basic information with some attempt made to link
or factors that affect it
knowledge and understanding to the given context.
OR
description of blood clotting process
Level 2
34
Demonstrates adequate knowledge and understanding by selecting and
Simple discussion of pharmacogenetics
applying some relevant biological facts / concepts. Consequences are
discussed which are occasionally supported through linkage to a range of
3 marks = implications of genotype for either gene M or
scientific ideas, processes, techniques and procedures. The discussion
gene V on warfarin dose
shows some linkages and lines of scientific reasoning with some
4 marks = implications of genotype for both gene M and
structure.
gene V on warfarin dose
Level 3
56
Demonstrates comprehensive knowledge and understanding by selecting
Understanding of other issues involved
and applying relevant biological facts / concepts. Consequences are
discussed which supported throughout by sustained linkage to a range of
5 marks = criteria for 4 marks plus links made with either
scientific ideas, processes, techniques and procedures. The discussion
blood clotting process or other factors or issues of
shows a welldeveloped and sustained line of scientific reasoning which is
screening
clear and logically structured.
6 marks = criteria for 4 marks plus links made with two
from blood clotting process / other factors / issues
surrounding screening
Make a free account to save your answers and see your weak topics and ask the AI why a wrong answer is wrong.

